These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 24317549

  • 1. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease.
    Cordeiro AC, Lindholm B, Sousa MG, Picotti JC, Nunes GJ, Santana MR, Grimaldi W, Amparo FC, Amodeo C, Carrero JJ.
    J Hypertens; 2014 Feb; 32(2):439-45. PubMed ID: 24317549
    [Abstract] [Full Text] [Related]

  • 2. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 3. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study.
    Zhang W, Zhou Y, Bai B, Yu S, Xiong J, Chi C, Teliewubai J, Li J, Blacher J, Zhang Y, Xu Y.
    Clin Interv Aging; 2019 May; 14():549-556. PubMed ID: 30880935
    [Abstract] [Full Text] [Related]

  • 4. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.
    Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M.
    Hypertension; 2004 Aug; 44(2):175-9. PubMed ID: 15226274
    [Abstract] [Full Text] [Related]

  • 5. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 6. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S, Sundh F, Schlegel T, Maynard C, Rück A, Wagner G, Ugander M.
    J Electrocardiol; 2015 Jan; 48(4):630-6. PubMed ID: 25865909
    [Abstract] [Full Text] [Related]

  • 7. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, Roussos D, Andreou I, Tsantilas A, Christoforatou E, Pitsavos C, Panagiotakos D, Stefanadis C.
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [Abstract] [Full Text] [Related]

  • 8. Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.
    Xie L, Wang Z.
    Hellenic J Cardiol; 2010 Aug; 51(5):391-401. PubMed ID: 20876051
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 14. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S, Sciacca RR, Sugioka K, Sacco RL, Homma S, Di Tullio MR.
    Am Heart J; 2005 Jan 12; 149(1):181-6. PubMed ID: 15660051
    [Abstract] [Full Text] [Related]

  • 15. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Jan 12; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients.
    Wang D, Xu JZ, Zhang W, Chen Y, Li J, An Y, Bian R, Wang JG.
    Am J Hypertens; 2020 Sep 10; 33(9):831-836. PubMed ID: 32484222
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E, Theofilis P, Mpahara A, Lazaros G, Niarchou P, Vogiatzi G, Tsalamandris S, Fountoulakis P, Christoforatou E, Mystakidou V, Anastasiou M, Goliopoulou A, Tousoulis D.
    Ann Noninvasive Electrocardiol; 2020 May 10; 25(3):e12728. PubMed ID: 31724804
    [Abstract] [Full Text] [Related]

  • 19. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients.
    Vernooij JW, Cramer MJ, Visseren FL, Korndewal MJ, Bots ML, Meijs MF, Doevendans PA, Spiering W, Smart Study Group.
    Am J Cardiol; 2012 Jul 15; 110(2):227-33. PubMed ID: 22483385
    [Abstract] [Full Text] [Related]

  • 20. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B.
    Am J Hypertens; 2001 Aug 15; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.